Early research (Phase 1)UnknownNCT04390984What this trial is testingDrug-drug Interaction Study of Gefitinb on Apatinib in NSCLC PatientsWho this might be right forNSCLC Jiangsu HengRui Medicine Co., Ltd. 22
Large-scale testing (Phase 3)Study completedNCT05807893What this trial is testingStudy to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain MetastasesWho this might be right forNon-small Cell Lung Cancer Stage IIBevacizumabImmunotherapy+1 more Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT00278460What this trial is testingGemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Wake Forest University Health Sciences 49
Testing effectiveness (Phase 2)Study completedNCT00117962What this trial is testingPemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 109
Large-scale testing (Phase 3)UnknownNCT03912389What this trial is testingEfficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLCWho this might be right forNon-Squamous Non-Small Cell Neoplasm of Lung Biocad 292
Testing effectiveness (Phase 2)Study completedNCT01266447What this trial is testingVeliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+5 more National Cancer Institute (NCI) 27
Not applicableStudy completedNCT04954885What this trial is testingEvaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and ToxicityWho this might be right forLung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8+2 more Ohio State University Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)UnknownNCT02942043What this trial is testingBevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung CancerWho this might be right forMalignant Pleural Effusion Peking University Cancer Hospital & Institute 87
Testing effectiveness (Phase 2)UnknownNCT02515435What this trial is testingThe Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Tongji University 40
Testing effectiveness (Phase 2)UnknownNCT03808480What this trial is testingNivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%Who this might be right forNon-small Cell Lung Cancer National Cancer Center, Korea 22
Early research (Phase 1)Ended earlyNCT03957096What this trial is testingA Safety Study of SGN-CD47M in Patients With Solid TumorsWho this might be right forSoft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more Seagen Inc. 16
Not applicableStudy completedNCT04552535What this trial is testingA Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the LungWho this might be right forSquamous Non-small Cell Lung Cancer Boehringer Ingelheim 200
Early research (Phase 1)Looking for participantsNCT07227168What this trial is testingSTRO-004 in Adults With Refractory/Recurrent Metastatic CancerWho this might be right forHead and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more Sutro Biopharma, Inc. 200
Large-scale testing (Phase 3)Study completedNCT03976362What this trial is testingPembrolizumab (MK-3475) With or Without Maintenance Olaparib in First-line Metastatic Squamous Non-small Cell Lung Cancer (NSCLC, MK-7339-008/KEYLYNK-008)Who this might be right forCarcinoma, Squamous Cell, Non-small-cell Lung Merck Sharp & Dohme LLC 851
Not applicableStudy completedNCT04490564What this trial is testingValidation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/MelanomaWho this might be right forHead and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma Pharmassist Ltd 135
Testing effectiveness (Phase 2)Ended earlyNCT00545948What this trial is testingAdjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Duke University 31
Testing effectiveness (Phase 2)UnknownNCT03750916What this trial is testingAnlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Qilu Hospital of Shandong University 46
Testing effectiveness (Phase 2)WithdrawnNCT03684967What this trial is testingStudy of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLCWho this might be right forLung Cancer Hutchison Medipharma Limited
Not applicableStudy completedNCT01015963What this trial is testingStudying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871Who this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 69
Not applicableStudy completedNCT01827852What this trial is testingAVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the LungWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 1,107